China - The Next Great Stock Market ? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : China - The Next Great Stock Market ?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: GREGG M. AKIN who wrote (60)	2/18/2003 8:32:24 AM
From: Crossy	Read Replies (1) of 140

re: DRUG.OB (Dragon Pharmaceutical) $0.65 China connection - genetically derived EPO and other drugs This pharmaceutical company bought into China (market & manufacturing) and is already a contender in the non-patented markets for EPO (China, Brazil etc.). In fact they have a production process of comparable purity with Amgen's but way better yield, hence a lot of cheaper. The company is already posting REAL REVENUES, not just "collaborative R&D money intake" as most other biotechs do. By 2004-2005 the Euro and US patents for EPO are going to expire. Dragon Pharma could emerge as a first-key source for generic EPO on a world scale level. I read their 10K and was really delighted.. some preliminary DD is here: Subject 49431 best rgrds CROSSY

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next